Angiomatoid fibrous histiocytoma of the adrenal gland: a clinical and pathological observation of two cases Authors: Li Yang, Li Xiao, Jiandi Li, Kanglai Wei, Lin Shi, Jun Chen, Gang Chen Published: 2025 ABSTRACT BackgroundAngiomatoid fibrous histiocytoma (AFH) is a rare low-grade neoplasm, typically arising in pediatric/adolescent extremity subcutaneous tissues. Adrenal AFH is extremely uncommon, with limited reported cases. Investigating the correlation between clinicopathological features (such as histomorphology and immunophenotype) and molecular findings (including genetic alterations like EWSR1 rearrangements) in adrenal AFH is essential for refining diagnostic accuracy and guiding targeted management strategies.Case presentationTwo adrenal AFH cases (18-year-old male, 50-year-old female) from Guangxi Medical University Second Hospital were retrospectively analyzed, focusing on clinical features, histopathology, immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and follow-up. Case 1: Classic AFH morphology with unique features: diffuse intratumoral lymphoid tissue (with follicles) instead of capsular lymphoid cuffs, and lymphangioma-like cystic spaces (lacking angiomatoid hemorrhage).Case 2: Cystic tumor misdiagnosed as "adrenal pseudocyst"; true parenchyma resided in the cyst wall, with nodular lymphoid aggregates (no lymphoid cuff) and erythrocyte/hemosiderin-filled vascular clefts. Marked hyaline fibrosis was noted. Molecular: Both cases showed EWSR1 break-apart (FISH +), negative for EWSR1::CREB1/ATF1 fusions. IHC revealed desmin positivity (both), ALK-D5F3 expression (Case 2).ConclusionsAtypical-location AFH (e.g., adrenal) exhibits divergent pathologic phenotypes. Diagnosis requires integrated IHC/molecular analysis (e.g., EWSR1 status). Prognostic implications of genetic alterations (e.g., ALK expression) highlight the need for molecular profiling to guide therapy and prognosis. Background Angiomatoid fibrous histiocytoma (AFH) was first described by Enzinger [1] in 1979 and represents an uncommon intermediate-grade soft tissue neoplasm, accounting for approximately 0.3% of all soft tissue tumors [2]. It exhibits low to intermediate malignant potential. Although AFH has a local recurrence rate of up to 12%, its metastatic rate is less than 1%, with distant lymph node metastasis being extremely rare and an overall low mortality rate [3]. The tumor predominantly arises in the subcutaneous soft tissues of the extremities, with the trunk and head and neck regions being secondary sites [4]. In contrast, adrenal involvement is exceptionally rare, with no cases found in the domestic literature and only a single case documented internationally [5]. Given its rarity and unique clinical presentation, investigating the clinicopathological and molecular characteristics of adrenal AFH is of significant importance. Herein, we report two cases of adrenal AFH from the Second Affiliated Hospital of Guangxi Medical University. In conjunction with a review of the literature, we analyze the clinicopathological features, immunohistochemical profiles, and molecular genetic findings of these tumors. This study aims to enhance the understanding of this uncommon tumour and inform diagnostic and therapeutic approaches. Case report Case 1 An 18-year-old male presented with recurrent abdominal pain and vomiting persisting for over 2 weeks. Contrast-enhanced computed tomography (CT) revealed a hypodense mass in the right adrenal region, measuring approximately 5.7 cm × 5.1 cm × 4.5 cm (Fig. 1A).Fig. 1A CT revealed a hypodense mass in the right adrenal region, with clear margins and measuring approximately 5.7 cm × 5.1 cm × 4.5 cm (red arrow). Contrast-enhanced scanning showed enhancement of the solid portion. B Gross examination showed the tumour with well-defined margins and a greyish-white, solid cut surface. Irregular cystic spaces were present, and scattered adrenal tissue was visible around the tumour (red arrow). C Microscopically, the tumour was encapsulated by fibrous tissue with focal involvement of the adrenal gland (red arrow). Tumour cells were arranged in nodular patterns with a histiocytoid appearance. Central cystic spaces or clefts were present without lining by epithelial or endothelial cells. Lymphoid tissue beneath the capsule formed a “lymphoid cuff” structure. D mmunohistochemical analysis revealed dendritic positivity for desmin. E FISH demonstrated positivity for the EWSR1 break-apart probe A CT revealed a hypodense mass in the right adrenal region, with clear margins and measuring approximately 5.7 cm × 5.1 cm × 4.5 cm (red arrow). Contrast-enhanced scanning showed enhancement of the solid portion. B Gross examination showed the tumour with well-defined margins and a greyish-white, solid cut surface. Irregular cystic spaces were present, and scattered adrenal tissue was visible around the tumour (red arrow). C Microscopically, the tumour was encapsulated by fibrous tissue with focal involvement of the adrenal gland (red arrow). Tumour cells were arranged in nodular patterns with a histiocytoid appearance. Central cystic spaces or clefts were present without lining by epithelial or endothelial cells. Lymphoid tissue beneath the capsule formed a “lymphoid cuff” structure. D mmunohistochemical analysis revealed dendritic positivity for desmin. E FISH demonstrated positivity for the EWSR1 break-apart probe The mass showed distinct margins and enhanced visibility of the solid component upon contrast scanning. The imaging differential diagnosis included pheochromocytoma and ganglioneuroma. Postoperative whole-body positron emission tomography-computed tomography (PET-CT) imaging showed no evidence of tumor. Gross examination The tumor measured 7 cm × 5.1 cm × 3.7 cm, was encapsulated, and had a smooth surface. The cut surface appeared grayish-white, of intermediate consistency, and solid, with irregular cystic spaces present. A small margin of adrenal tissue was identified around the tumor (Fig. 1B). Microscopic examination The tumor was characterized by a thick fibrous capsule, well-demarcated from the surrounding adrenal tissue in most areas, with focal involvement of the adrenal gland (Fig. 1C). Beneath the fibrous capsule, there was extensive lymphocytic and plasma cell proliferation, with the formation of lymphoid follicles creating a ‘lymphoid cuff’ structure. Significant fibroproliferation was observed, with fibrous tissue extending into the tumor parenchyma and forming a multinodular architecture by encircling and separating the tumor cells. The tumor exhibited a mixed cystic and solid pattern, with tumor cells arranged in nodular or sheet-like formations predominantly surrounding areas of cystic degeneration. The tumor cells had a histiocytoid appearance, with round or oval nuclei, small nucleoli, and occasional nuclear grooves. The cytoplasm was lightly eosinophilic, with indistinct borders, and no mitotic figures were identified. Notably, within the cystic spaces of the tumor, most were empty or contained a small amount of eosinophilic fluid, with only a few containing a small number of red blood cells. Importantly, none of the cystic spaces were lined by epithelial or endothelial cells. Immunophenotyping demonstrated dendritic positivity for desmin (Fig. 1D), in addition to the expression of EMA, CD99, and SMA. Immunostaining was negative for CD68, ALK, CD31, CD34, CD21, and CD35. The Ki-67 proliferation index was 5%. Fluorescence in situ hybridization (FISH) demonstrated positivity for the EWSR1 break-apart probe (Fig. 1E), whereas probes for EWSR1::CREB1 and EWSR1::ATF1 gene fusions were negative. Case 2 A 50-year-old female presented without significant clinical symptoms but was found to have a right adrenal mass on examination. She visited a local hospital after detecting the mass 6 days prior. CT at the local hospital revealed an irregular soft tissue density mass in the right adrenal region, with heterogeneous internal density, and a maximum size of approximately 6.4 cm × 7.5 cm × 7.6 cm. Contrast-enhanced scanning showed heterogeneous enhancement of the mass, with a lobulated appearance. The boundary between the lesion and the diaphragm was indistinct, and the adjacent right diaphragm was slightly thickened. The surrounding fat planes were blurred, with patchy areas of infiltration, and enlarged lymph nodes were visible around the mass (Fig. 2A). The imaging findings indicated a malignant adrenal tumor with right diaphragm invasion and metastasis to adjacent lymph nodes. The patient underwent right adrenal tumor resection and partial right adrenalectomy. The postoperative pathological diagnosis was “adrenal pseudocyst.”Fig. 2A CT at the local hospital revealed an irregular soft tissue density mass in the right adrenal region, with heterogeneous internal density and a maximum size of approximately 6.4 cm × 7.5 cm × 7.6 cm (red arrow). B CT plain scan and contrast-enhanced imaging at our institution revealed a mass-like area of abnormal density in the right adrenal region, measuring approximately 3.2 cm × 2.4 cm × 3.0 cm (red arrow). C The tumor is cystic with a thick fibrous cyst wall. The inner cyst wall is infiltrated by numerous lymphocytes and plasma cells. Focal areas demonstrate a vascular cleft-like appearance containing large numbers of red blood cells and hemosiderin deposits. Focal clusters of histiocytoid cells are present (red arrow). D Metastatic tumor focus in the iliac bone. E Dendritic positivity for desmin. F Positivity for ALK-D5F3 A CT at the local hospital revealed an irregular soft tissue density mass in the right adrenal region, with heterogeneous internal density and a maximum size of approximately 6.4 cm × 7.5 cm × 7.6 cm (red arrow). B CT plain scan and contrast-enhanced imaging at our institution revealed a mass-like area of abnormal density in the right adrenal region, measuring approximately 3.2 cm × 2.4 cm × 3.0 cm (red arrow). C The tumor is cystic with a thick fibrous cyst wall. The inner cyst wall is infiltrated by numerous lymphocytes and plasma cells. Focal areas demonstrate a vascular cleft-like appearance containing large numbers of red blood cells and hemosiderin deposits. Focal clusters of histiocytoid cells are present (red arrow). D Metastatic tumor focus in the iliac bone. E Dendritic positivity for desmin. F Positivity for ALK-D5F3 Over a year postoperatively, the patient experienced recurrent fever for half a year and presented to our hospital. CT at our institution revealed a mass-like area of abnormal density in the right adrenal region, measuring approximately 3.2 cm × 2.4 cm × 3.0 cm. Contrast-enhanced scanning showed heterogeneous mild enhancement, with unclear boundaries. The lesion was indistinguishable from the adjacent right kidney, inferior vena cava, and right diaphragm (Fig. 2B). Imaging diagnosis considered: postoperative recurrence of the tumor with possible metastasis to the para-aortic lymph nodes and left iliac bone. Involvement of the right kidney, inferior vena cava, right diaphragm, right peritoneum, liver, left iliac vessels, gluteus maximus, and quadratus femoris muscles could not be excluded. Metastasis to the intermuscular lymph nodes remained to be ruled out. Consequently, a consultation of the patient’s original pathology slides was conducted, and a biopsy of the left iliac bone was performed. The corrected pathological diagnosis was angiomatoid fibrous histiocytoma (AFH) of the adrenal gland with metastasis to the iliac bone. Gross examination The tumor measured 9.5 cm × 6 cm × 5 cm. The surface was partially encapsulated. The cut surface appeared grayish-brown, with a cystic and solid appearance, and showed evidence of hemorrhage and necrosis. Microscopic examination The tumor exhibited a cystic architecture with a thick fibrous cyst wall. The cyst wall exhibited extensive lymphocyte and plasma cell proliferation, with occasional lymphoid follicle formation. Vascular cleft-like structures were present within the cyst wall, containing numerous red blood cells and hemosiderin deposits, none of which were lined by epithelial or endothelial cells (Fig. 2C). Tumor cells were arranged in small clusters or nests, with some areas extending beyond the fibrous cyst wall. The tumor cells had a histiocytoid appearance with visible mitotic figures (approximately 3/10high-power fields [HPF]). Significant interstitial fibrosis with hyaline degeneration was also observed. In the iliac bone metastasis, the tumor cells exhibited a histiocytoid morphology with minimal cytologic atypia (Fig. 2D). Immunophenotyping analysis revealed dendritic positivity for desmin (Fig. 2E), with expression of ALK-D5F3 (Fig. 2F), epithelial membrane antigen (EMA), and CD99. The tumour was negative for CD68, S-100, CD31, CD34, CD21, and CD35. The Ki-67 proliferation index was 10%. FISH demonstrated positivity for the EWSR1 break-apart probe, whereas probes for EWSR1::CREB1 and EWSR1::ATF1 gene fusions were negative. Discussion Clinical features AFH predominantly affects children and adolescents, with a mean age of approximately 20 years. The two cases reported herein include an 18-year-old patient (Case 1), which aligns with the previously reported age distribution, and a 50-year-old patient (Case 2), suggesting that adrenal AFH may have a broader age range and is not exclusive to children and adolescents. AFH typically occurs in superficial locations of the extremities; however, both cases in this report originated in the adrenal glands, an exceedingly rare site for this tumor. To date, no similar cases have been reported domestically, with only one case documented internationally [5]. Clinically, Case 1 presented with recurrent abdominal pain and vomiting, while Case 2 was largely asymptomatic initially, later developing unexplained recurrent fever following tumor recurrence, which is consistent with the clinical manifestations of adrenal AFH reported in the literature [5]. In terms of biological behavior, AFH is generally considered to have low malignant potential or intermediate characteristics. Due to the uncertain differentiation of tumor cells, the WHO classification groups AFH under the category of “tumors of uncertain differentiation” [6]. The clinical behavior of the two cases in this study varied significantly: Case 1 exhibited benign features with no recurrence postoperatively, whereas Case 2 demonstrated aggressive behavior, with local invasion into surrounding soft tissues and metastasis to bone, a manifestation that is highly unusual for AFH. Pathological characteristics Gross features AFH typically presents as well-circumscribed tumours with diameters ranging from 0.7 to 12 cm. Upon sectioning, they appear greyish-brown with a firm texture and exhibit irregular haemorrhagic cystic spaces. The two cases reported herein had relatively large tumours, with diameters of 7 cm and 9 cm, respectively. Case 1 exhibited a cystic-solid appearance with inconspicuous intra-cystic haemorrhage, whereas Case 2 presented as a cystic tumour accompanied by prominent haemorrhage. Morphological features Classical AFH displays the following three characteristic pathological morphologies: (1) The tumor periphery is encircled by a substantial infiltrate of lymphocytes and plasma cells, often forming a"lymphatic cuff"that fuses with a fibrous pseudocapsule; (2) The central neoplastic parenchyma comprises nodular, irregularly sheet-like, and nest-like spindle-to-oval histiocyte-like cells. The nuclei exhibit a round or oval morphology, with small nucleoli and prominent nuclear grooves. (3) The tumor contains multifocal hemorrhagic cystic spaces devoid of endothelial lining. Case 1 in this study exhibits morphological concordance with classical AFH, yet it possesses unique features that differentiate it. Notably, the lymphatic tissue is not confined to the periphery of the capsule but is diffusely distributed within the tumour parenchyma, accompanied by the formation of numerous lymph follicles. In the literature, the presence of a “lymphatic cuff” is considered a significant diagnostic clue for solid-variant AFH, observed in approximately 80% of cases [7]. However, Case 1 lacks a prominent “lymphatic cuff” structure. Although cystic spaces are formed within the tumor, intra-cystic hemorrhage is inconspicuous, lacking the typical “angiogenic” features and resembling more of a “lymphangioma-like” appearance. Case 2 presents as a cystic tumor with a relatively thick fibrous capsule, initially misdiagnosed as an “adrenal pseudocyst” by the original institution. In reality, the capsule wall represents the true tumor parenchyma. In this case, the lymphatic tissue does not form a “lymphatic cuff”-like structure but is instead scattered in nodular fashion, with only a few lymph follicles visible. Cyst formation is not prominent, manifesting more as vascular lumen-like fissures containing abundant red blood cells and hemosiderin. Marked interstitial fibrosis with hyalinization is also noted, inconsistent with the mucinous features commonly reported in intracranial AFH in the literature [8]. The two cases reported herein do not fully conform morphologically to classical AFH, solid-variant AFH, or AFH located in other special sites, thereby providing additional morphological characteristics for AFH. Of particular note is Case 2, where the tumor cells showed minimal atypia and only a few mitotic figures both at the time of surgery and upon recurrence. Nevertheless, the tumor demonstrated malignant behavior with surrounding tissue infiltration and metastasis. Therefore, it is speculated that the biological behavior of AFH occurring in the adrenal gland is not directly related to cellular atypia and mitotic figures but may be more associated with specific genetic alterations. Immunophenotypic characteristics The tumor cells in both patients expressed EMA, CD99, and Desmin, with Desmin demonstrating a dendritic positivity. The tumor cells in Case 2 expressed ALK-D5F3, while both cases were negative for CD34, CD21, and CD35. The negativity for CD34 suggests the absence of endothelial cell lining within the vascular lacunae of the tumor. Approximately 90% of cases express the ALK protein [9], however, current studies indicate that cases expressing ALK protein do not have amplification or mutation of the ALK gene, and the mechanism of ALK expression remains unclear. Molecular pathological features Studies have demonstrated that over 80%–90% of angiomatoid fibrous histiocytoma (AFH) cases harbor the EWSR1::CREB1 fusion gene, with a minority of cases also showing EWSR1::ATF1 or FUS::ATF1 fusion genes [10, 11]. In the present study, fluorescence in situ hybridization (FISH) analysis revealed EWSR1 gene rearrangement in both cases, yet further testing for EWSR1::CREB1 and EWSR1::ATF1 fusions was negative. Similar findings have been reported in a subset of AFH cases, where only EWSR1 gene rearrangement was detected without the common fusion partners CREB1 or ATF1 [9]. Similar observations have also been reported in pediatric AFH cases [12]. Unfortunately, due to financial constraints, next-generation sequencing (NGS) could not be performed to identify additional fusion genes, which represents a significant limitation, especially in Case 2. We hypothesize that the observed aggressive biological behavior in this case could be linked to an EWSR1-related fusion gene alteration. Differential diagnosis Hematoma and Hemangioma: The majority of AFH tumors are often accompanied by the formation of irregular cystic cavities, which can easily be confused with hematoma or hemangioma. Case 2 in this study was initially misdiagnosed as a pseudocyst due to its cystic tumor wall with sparse tumor cells and no lining cells. However, AFH is negative for endothelial cell markers (such as CD31, CD34, etc.), indicating that the cells within the cyst wall are not endothelial cells, and the irregular hemorrhagic clefts are not true vascular lumens. This distinction can be made to differentiate AFH from hematoma or hemangioma [13]. Lymph Node Metastasis of Tumor: AFH is surrounded by a fibrous pseudocapsule with a large number of lymphocytes subcapsularly and may form germinal centers, which can lead to misdiagnosis as lymph node metastasis of a tumor. However, AFH lacks lymphatic sinus structures, and the germinal centers do not distribute subcapsularly. These features are helpful in differentiation. Aneurysmal Fibrous Histiocytoma (AFH-like in name but distinct pathologically): While the name is somewhat similar to AFH, aneurysmal fibrous histiocytoma belongs to an entirely different pathology. The former is located in the dermis, lacks a pseudocapsule, and is characterized by the presence of abundant cleft-like or blood sinus-like capillaries within the tumor. The solid areas surrounding the blood vessels exhibit the classic morphology of fibrous histiocytoma, and the stroma commonly contains abundant hemosiderin deposition and aggregations of hemosiderin-laden macrophages. Treatment and prognosis The primary treatment for angiomatoid fibrous histiocytoma (AFH) is wide surgical excision, with negative margins being crucial. The local recurrence rate after complete resection ranges from 2 to 10%. Costa et al. reported that irregular tumor borders and head and neck locations are associated with local recurrence, while tumor depth is correlated with subsequent local and distant metastasis. However, the associations between mitotic activity, nuclear pleomorphism, inflammatory response, tumor size, patient age, and adjuvant therapy with clinical behavior remain unclear [6]. To date, no reports have demonstrated a correlation between genetic factors or immunohistochemical profiles and clinical behavior. Therefore, for surgical treatment of AFH, ensuring wide excision and negative margins is essential. Radiotherapy or chemotherapy is typically considered for large tumors, those with distant metastasis, or those located near major vessels [14], and long-term close follow-up is required. In this study, Case 2 developed metastasis to the iliac bone and underwent AI chemotherapy, which showed suboptimal efficacy. Recent studies have shown that the ALK inhibitor crizotinib can provide a cure or remission in recurrent AFH cases with ALK protein expression [15], suggesting that targeted therapy may represent a future direction for treatment. Conclusion In conclusion, angiomatoid fibrous histiocytoma (AFH) occurring in atypical sites (such as the adrenal gland) may exhibit unique histological features, such as the abnormal distribution of lymphoid tissue, variations in cystic cavity characteristics, and stromal fibrosis. These features have certain suggestive value for diagnosis; however, a definitive diagnosis still requires the integration of immunophenotypic (e.g., dendritic positivity for Desmin) and molecular testing (e.g., EWSR1 breakage) results. The differences in clinical behavior (benign vs. malignant manifestations) between the two cases in this study suggest that the prognosis of AFH may be associated with specific genetic alterations. Nevertheless, this study only included 2 cases of adrenal AFH, which may not fully reflect the overall pathological characteristics and biological behavior patterns of AFH in this site, and further verification with studies involving larger sample sizes is required. In-depth exploration of the molecular biological characteristics of such rare tumors may provide references for optimizing diagnostic procedures, treatment strategies, and prognostic evaluation. Overall, the case reports presented herein further expand the spectrum of adrenal tumours and offer new insights into the diagnosis and study of AFH in rare locations.